APM: Utang jangka cendhak marang ekuitas Aptorum
Aptorum Group Limited (APM) is currently optimizing its portfolio of drugs targeting infections and rare pathologies while awaiting a strategic partnership. The business relies on identifying Asian biotech startups for their subsequent launch into the global market. This price chart featuring the 0.15 indicator reflects the asset's dynamics as the Hong Kong-based management seeks to validate its experience in conducting US clinical trials.
Rincian analitis perusahaan Aptorum (APM)
- rega lan prakiraan konsensus rega:
- data kapitalisasi pasar:
- data kapitalisasi buku:
- data utang lan likuiditas:
Rasio Total Utang marang Ekuitas Aptorum Group Limited|APM - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Aptorum Group Limited|APM - Utang kumulatif perusahaan|Utang marang nilai buku Aptorum Group Ltd|APM - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan Aptorum Group
Analisis fundamental perusahaan:APM, Aptorum Group
For the biotechnology company Aptorum Group Limited (APM), which invests in laboratory greening and ESG filtration, the ratio of short-term borrowing to equity reflects the balance between operational flexibility and debt load. This metric compares liabilities maturing within one year against equity, allowing investors to assess liquidity risk and the efficiency of working capital management in sustaining the pace of technological growth.
Analisis perusahaan pesaing
Utang jangka cendhak marang modal HLN|Utang jangka cendhak marang modal KVUE (Kenvue Health)|Utang jangka cendhak marang ekuitas Verona Pharma plc|jyongbio.com - Rasio tanggungan utang jangka cendhak marang modal|LGND: Utang jangka cendhak marang ekuitas|AMRX - Rasio utang jangka cendhak marang ekuitas|PRGO: Utang jangka cendhak marang modal|Utang jangka cendhak marang modal Alvotech Biopharmaceuticals|LQDA - Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal GLPG|ANI Pharmaceuticals, Inc. - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal MannKind Corp MNKD|Rasio utang jangka cendhak marang ekuitas Amphastar (AMPH)|Rasio silihan jangka cendhak marang modal Pacira Corp PCRX|Utang jangka cendhak marang modal ARS Pharmaceuticals (SPRY)|TBPH - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal AQST|SCPH (scPharmaceuticals) - Kewajiban jangka cendhak marang modal|TECX - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Tonix Pharmaceuticals Holding|Utang jangka cendhak marang modal SXTC|Utang jangka cendhak marang modal EPRX (eupraxiapharma.com)|BioHarvest Sciences Inc. (BHST) - Utang jangka cendhak marang ekuitas|EXOZ - Kewajiban jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Oramed Pharma ORMP|ENTX: Rasio silihan jangka cendhak marang modal|Utang jangka cendhak marang ekuitas HYFT|ABVC (abvcpharma.com) - Kewajiban jangka cendhak marang modal|CPIX - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Quantum BioPharma Ltd. (QNTM)|Rasio utang jangka cendhak marang ekuitas FGEN|Utang jangka cendhak marang modal TELO (Telomir Pharmaceuticals Corp)|Rani Therapeutics Holdings, Inc. - Utang jangka cendhak marang ekuitas|SNYR - Rasio utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Rallybio Corp. (RLYB)|LEXX - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal PULM (Pulmatrix Corp)|PTHL (Pheton Holdings) - Tanggungan utang jangka cendhak marang ekuitas|LYRA - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal IBO|TNF Pharmaceuticals - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal cbdmd.com YCBD|Rasio utang jangka cendhak marang ekuitas PRFX (PainReform Limited)|Altamira Therapeutics Ltd - Utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Lipella Pharmaceuticals|optinose.com (OPTN) - Kewajiban jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Pieris Pharmaceuticals, Inc. PIRS|PROC (Procaps Group) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Petros|Utang jangka cendhak marang ekuitas Qilian International Corp|SLRN (Acelyrin, Inc.) - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal TFFP (tffpharma.com)